Data from the second cohort showed the vaccine to be 45.0% effective in extending time to first infection (95% CI, 31.4 - 55.9; P < .0001).

A nurse administers a malaria vaccine to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. [VOA] The World Health Organization on Monday announced the recommendation of ...

Vaxart’s second-generation technology was developed in 2023 and 2024 to achieve two purposes: first, to increase expression levels of the antigen proteins, and thus to greatly increase antibody ...

A monoclonal antibody (mAb), L9LS, shows promise in preventing malaria infection, according to the results of a small, proof-of-concept study reported in The New England Journal of Medicine. Of 17 ...

The Indian Council of Medical Research (ICMR) has called upon domestic vaccine manufacturers to collaborate in launching and ...

This tiny insect is responsible for spreading malaria, a disease that infected nearly 250 million people in 2022 and killed more than 600,000 of them.

LONDON, June 25 (Reuters) - Drugmakers Bharat Biotech and GSK (GSK.L), opens new tab will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost ...